Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥50% reduction from baseline versus <70 mg/dL

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 478-485

  Cho, Kyung Hoon ^a   Jeong, Myung Ho ^a   Park, Kyung Woo ^b   Kim, Hyo Soo ^b   Lee, Sang Rok ^c   Chae, Jei Keon ^c   Hong, Young Joon ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Cholesterol; Myocardial infarction; Prevention; Statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONFATAL MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SECONDARY PREVENTION; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MOTIVATION; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; PROSPECTIVE STUDY; REGISTER; SOUTH KOREA; TREATMENT OUTCOME;

CHOLESTEROL, LDL; FEMALE; GOALS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; REPUBLIC OF KOREA; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 84929307072     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.386     Document Type: Article

References (20)

1. C. Baigent, L. Blackwell, J. Emberson, et al., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet 376 (2010) 1670-1681.
2. Z. Reiner, A.L. Catapano, G. De Backer, et al., ESC/EAS Guidelines for the Management of Dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Eur. Heart J. 32 (2011) 1769-1818.
3. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, et al., AHA/ACCF Secondary Prevention and Risk Reduction Therapy For Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 update: a guideline from the american heart association and american college of cardiology foundation, Circulation 124 (2011) 2458-2473.
4. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, et al., 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 61 (2013) e78-e140.
5. N.J. Stone, J. Robinson, A.H. Lichtenstein, et al., 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol. 63 (2014) 2889-2934.
6. S.S. Martin, T.T. Abd, S.R. Jones, E.D. Michos, R.S. Blumenthal, M.J. Blaha, 2013 ACC/AHA Cholesterol Treatment Guideline: what was done well and what could be done better, J. Am. Coll. Cardiol. 63 (2014) 2674-2678.
7. K.Y. Chen, S.W. Rha, Y.J. Li, et al., Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, Circulation 119 (2009) 3207-3214.
8. L.G. Shewan, A.J. Coats, Adherence to ethical standards in publishing scientific articles: a statement from the International Journal of Cardiology, Int. J. Cardiol. 161 (2012) 124-125.
9. C.M. Gibson, A. Schomig, Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion, Circulation 109 (2004) 3096-3105.
10. F.C. Brosius III, T.H. Hostetter, E. Kelepouris, et al., Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation, Circulation 114 (2006) 1083-1087.
11. C.P.Cannon,E.Braunwald, C.H.McCabe,et al., Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N. Engl. J. Med. 350 (2004) 1495-1504.
12. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, et al., Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial, JAMA 292 (2004) 1307-1316.
13. J.C. LaRosa, S.M. Grundy, D.D. Waters, et al., Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N. Engl. J. Med. 352 (2005) 1425-1435.
14. T.R. Pedersen, O. Faergeman, J.J. Kastelein, et al., High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial, JAMA 294 (2005) 2437-2445.
15. J. Armitage, L. Bowman, K. Wallendszus, et al., Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial, Lancet 376 (2010) 1658-1669.
16. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet 360 (2002) 7-22.
17. F.A. Spencer, R.J. Goldberg, J.M. Gore, et al., Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein > or =100 mg/dl versus <100 mg/dl, Am. J. Cardiol. 100 (2007) 913-918.
18. K.H. Lee, M.H. Jeong, H.M. Kim, et al., Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol, J. Am. Coll. Cardiol. 58 (2011) 1664-1671.
19. N.J. Leeper, R. Ardehali, E.M. deGoma, P.A. Heidenreich, Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival, Circulation 116 (2007) 613-618.
20. T. Nozue, S. Yamamoto, S. Tohyama, et al., Impacts of age on coronary atherosclerosis and vascular response to statin therapy, Heart Vessels 29 (2014) 456-463.